Ferroptosis Affects the Progression of Nonalcoholic Steatohepatitis via the Modulation of Lipid Peroxidation–Mediated Cell Death in Mice

Cited by (344)

Items 101–200 of 344

1. Dual TBK1/IKKε inhibitor amlexanox mitigates palmitic acid-induced hepatotoxicity and lipoapoptosis in vitro
   Zixiong Zhou, Jing Qi, Chae Woong Lim, Jong-Won Kim, Bumseok Kim · 2020 · Toxicology
2. Unraveling the interplay between iron homeostasis, ferroptosis and extramedullary hematopoiesis
   Victoria Fernández-García, Silvia González-Ramos, Paloma Martín‐Sanz, Antonio Castrillo, Lisardo Boscá · 2022 · Pharmacological Research
3. Zeaxanthin prevents ferroptosis by promoting mitochondrial function and inhibiting the p53 pathway in free fatty acid-induced HepG2 cells
   Huimin Liu, Jie Yan, Fengtao Guan, Zhibo Jin, Jiahan Xie, Chongrui Wang, Meihong Liu, Jingsheng Liu · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
4. Angiotensin II Induces Vascular Endothelial Dysfunction by Promoting Lipid Peroxidation-Mediated Ferroptosis via CD36
   Qian Zhou, Ying Zhang, Wei Shi, Lu Lu, Jianglan Wei, Jinhan Wang, Hu Zhang, Yuepu Pu, Lihong Yin · 2024 · Biomolecules
5. Ferroptosis: Shedding Light on Mechanisms and Therapeutic Opportunities in Liver Diseases
   Hongmei You, Ling Wang, Fangtian Bu, Hongwu Meng, Cheng Huang, Guo-ying Fang, Jun Li · 2022 · Cells
6. Hepatocyte programmed cell death: the trigger for inflammation and fibrosis in metabolic dysfunction-associated steatohepatitis
   Zilu Cheng, Huikuan Chu, Ekihiro Seki, Rong Lin, Ling Yang · 2024 · Frontiers in Cell and Developmental Biology
7. The oxidized phospholipid PGPC impairs endothelial function by promoting endothelial cell ferroptosis via FABP3
   Si Xuan Chen, Jianjun Gao, Yu-Jia Liu, Zhi-Wei Mo, Fang-Yuan Wu, Zuojun Hu, Yue-Ming Peng, Xiaoqin Zhang, Zhen-Sheng Ma, Ze-Long Liu et al. · 2024 · Journal of Lipid Research
8. Urolithin C reveals anti-NAFLD potential via AMPK-ferroptosis axis and modulating gut microbiota
   Jingyuan Xu, Hongyang Tian, Yajun Ji, Lei Dong, Yandong Liu, Yatao Wang, Xuefen Gao, Haitao Shi, Hong Li, Longbao Yang · 2023 · Naunyn-Schmiedeberg s Archives of Pharmacology
9. A regulatory module comprising G3BP1-FBXL5-IRP2 axis determines sodium arsenite-induced ferroptosis
   Qian Liu, Fengli Wang, Yingxian Chen, Hengkang Cui, Hao Wu · 2023 · Journal of Hazardous Materials
10. Targeted Ferroptosis-Immunotherapy Synergy: Enhanced Antiglioma Efficacy with Hybrid Nanovesicles Comprising NK Cell-Derived Exosomes and RSL3-Loaded Liposomes
    Wenyan Hao, Nan Sun, Yueyue Fan, Mengyu Chen, Qianqian Liu, Meiyan Yang, Yang Yang, Chunsheng Gao · 2024 · ACS Applied Materials & Interfaces
11. Interaction between iron and omega-3 fatty acids metabolisms: where is the cross-link?
    Magdalena Ogłuszka, Paweł Lipiński, Rafał R. Starzyński · 2020 · Critical Reviews in Food Science and Nutrition
12. The Regulatory Roles of Polysaccharides and Ferroptosis-Related Phytochemicals in Liver Diseases
    Yijing Ren, Siyue Li, Zixuan Song, Qiuping Luo, Yingying Zhang, Hao Wang · 2022 · Nutrients
13. Ferroptosis in Chronic Liver Diseases: Opportunities and Challenges
    Grace Zhou, Yadong Fu, Wei Liu, Yongping Mu, Hua Zhang, Jiamei Chen, Ping Liu · 2022 · Frontiers in Molecular Biosciences
14. Ferroptosis as a potential new therapeutic target for diabetes and its complications
    Qian Deng, Yue Zhu, Mengmeng Zhang, Aihua Fei, Jiaqi Liang, Jinjin Zheng, Qingping Zhang, Tong Cheng, Xia Ge · 2023 · Endocrine Connections
15. San-Huang-Yi-Shen capsule ameliorates diabetic nephropathy in mice through inhibiting ferroptosis
    Shuquan Lv, Huajun Li, Tianyu Zhang, Xiuhai Su, Wenjuan Sun, Qinghai Wang, Lixin Wang, Nana Feng, Shufang Zhang, Yuansong Wang et al. · 2023 · Biomedicine & Pharmacotherapy
16. Effect of natural polysaccharides on alcoholic liver disease: A review
    Siyu Li, Xin Zhou, Ruhai Chen, Qiurong Zhang, Yu Sun, Huaguo Chen · 2023 · International Journal of Biological Macromolecules
17. Regulatory mechanisms of amino acids in ferroptosis
    Heying Yao, Wei Jiang, Xiang Liao, Dongqing Wang, Haitao Zhu · 2024 · Life Sciences
18. TEC-mediated tRF-31R9J regulates histone lactylation and acetylation by HDAC1 to suppress hepatocyte ferroptosis and improve non-alcoholic steatohepatitis
    Juanjuan Zhu, Xian Wu, Mao Mu, Quan Zhang, Xueke Zhao · 2025 · Clinical Epigenetics
19. Ferroptosis: A New Strategy for Cancer Therapy
    Yu Chen, Zhihua Fan, Shen Hu, Chengchao Lu, Yi Xiang, Shuzhi Liao · 2022 · Frontiers in Oncology
20. Ferroptosis in COVID-19-related liver injury: A potential mechanism and therapeutic target
    Yunqing Chen, Yan Xu, Kan Zhang, Liang Shen, Min Deng · 2022 · Frontiers in Cellular and Infection Microbiology
21. Attenuation by Time‐Restricted Feeding of High‐Fat and High‐Fructose Diet‐Induced NASH in Mice Is Related to Per2 and Ferroptosis
    Yan-Yun Shu, Wenkang Gao, Huikuan Chu, Ling Yang, Xiaoli Pan, Jin Ye · 2022 · Oxidative Medicine and Cellular Longevity
22. Current, emerging, and potential therapies for non-alcoholic steatohepatitis
    Zhen Lu Yang, Lin Wang · 2023 · Frontiers in Pharmacology
23. Ferroptosis as an emerging therapeutic target in liver diseases
    Yuzhen Lu, Junjie Hu, Liang Chen, Shan Li, Ming Yuan, Xianxiang Tian, Peng Cao, Zhenpeng Qiu · 2023 · Frontiers in Pharmacology
24. Unveiling the role of ferroptosis in the progression from NAFLD to NASH: recent advances in mechanistic understanding
    Qian Yu, Lixing Song · 2024 · Frontiers in Endocrinology
25. Ginsenoside Rg1 exerts anti‑apoptotic effects on non‑alcoholic fatty liver cells by downregulating the expression of SGPL1
    Guiming Li, Hongqing Xie, Xiaodie Cao, Chong Ma, Yan Li, Li Chen · 2022 · Molecular Medicine Reports
26. Multifunctional Fe3O4-PEI@HA nanoparticles in the ferroptosis treatment of hepatocellular carcinoma through modulating reactive oxygen species
    Ziwei Liang, Yuhui Wang, Jiapu Wang, Tao Xu, Shilong Ma, Qi Liu, Liqin Zhao, Yan Wei, Xiaojie Lian, Di Huang · 2023 · Colloids and Surfaces B Biointerfaces
27. Iron metabolism and ferroptosis in nonalcoholic fatty liver disease: what is our next step?
    Xiang Shen, Ziqi Yu, Changli Wei, Chong Hu, Jianyong Chen · 2024 · American Journal of Physiology-Endocrinology and Metabolism
28. Cell Death in Liver Disease and Liver Surgery
    Christian Stoess, Yeon‐Kyung Choi, Janset Onyuru, Helmut Friess, Hal M. Hoffman, Daniel Hartmann, Ariel E. Feldstein · 2024 · Biomedicines
29. The Role of Iron in Atherosclerosis and its Association with Related Diseases
    Yingbo Gao, Boda Wang, Mengrui Hu, Yuhan Ma, Bin Zheng · 2024 · Current Atherosclerosis Reports
30. Role of ferroptosis in periodontitis: An animal study in rats
    Earl Fu, Chan‐Yen Kuo, Yi‐Jan Hsia, Yiao‐Mien Huang, Hui‐Hwa Tseng, Min‐Wen Fu, Kuang‐Chung Shih · 2023 · Journal of Periodontal Research
31. Autophagy, Ferroptosis, Apoptosis and Pyroptosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Shuang-Shuang Zhao, Yan Guo, Xunzhe Yin · 2024 · Frontiers in Bioscience
32. Depletion of Igfbp7 alleviates zebrafish NAFLD progression through inhibiting hepatic ferroptosis
    Yanqin Wang, Jiaqi Bo, Zhonghua Zhao, Yuhang Han, Qianqian Zhang, Lixin Liu · 2023 · Life Sciences
33. Hepatic Oxidative Stress and Cell Death Influenced by Dietary Lipid Levels in a Fresh Teleost
    Lingjie He, Yupeng Zhang, Quanquan Cao, Hongying Shan, Jiali Zong, Lin Feng, Wei‐Dan Jiang, Pei Wu, Juan Zhao, Haifeng Liu et al. · 2024 · Antioxidants
34. Orostachys japonicus ameliorates acetaminophen-induced acute liver injury in mice
    Zixiong Zhou, Jing Qi, Jing Zhao, Jeong Hun Seo, Dong Gue Shin, Jeong‐Dan Cha, Chae Woong Lim, Jong-Won Kim, Bumseok Kim · 2020 · Journal of Ethnopharmacology
35. Ferroptosis in Liver Disease: Natural Active Compounds and Therapeutic Implications
    Zhili Wu, Yanru Zhu, Wen‐Chao Liu, Balamuralikrishnan Balasubramanian, Xiao Lin Xu, Junhu Yao, X. J. Lei · 2024 · Antioxidants
36. Porphyromonas gingivalis triggers inflammation in hepatocyte depend on ferroptosis via activating the NF‐κB signaling pathway
    Chao Hua Yao, Dongmei Lan, Xue Li, Yan Wang, Shengcai Qi · 2023 · Oral Diseases
37. The Role of Oxidative Stress and Cellular Senescence in the Pathogenesis of Metabolic Associated Fatty Liver Disease and Related Hepatocellular Carcinoma
    Nikolaos-Andreas Anastasopoulos, Antonia V. Charchanti, Alexandra Barbouti, Eleftheria M. Mastoridou, ANNA C. GOUSSIA, Anastasia D. Karampa, Dimitrios K. Christodoulou, Georgios K. Glantzounis · 2023 · Antioxidants
38. The Emerging Role of Ferroptosis in Various Chronic Liver Diseases: Opportunity or Challenge
    Lujian Zhu, Shengnan Luo, Yin Zhu, Shiyue Tang, Chenge Li, Xiaozhi Jin, Fa-Ling Wu, Huimian Jiang, Lina Wu, Yejin Xu · 2023 · Journal of Inflammation Research
39. Ferroptosis: a new target for hepatic ischemia-reperfusion injury?
    Shanshan Guo, Zexin Li, Yi Liu, Ying Cheng, Degong Jia · 2024 · Free Radical Research
40. Inhibiting Ferroptosis Prevents the Progression of Steatotic Liver Disease in Obese Mice
    Gi-Cheol Park, Soo-Young Bang, Ji Min Kim, Sung‐Chan Shin, Yong-Il Cheon, Kwang Min Kim, Hanaro Park, Eui‐Suk Sung, Minhyung Lee, Jin‐Choon Lee et al. · 2024 · Antioxidants
41. Targeting ferroptosis with natural products in liver injury: new insights from molecular mechanisms to targeted therapies
    Yongyi Liang, Shaojun Qiu, Youwen Zou, Lianxiang Luo · 2023 · Phytomedicine
42. BACH1 inhibits senescence, obesity, and short lifespan by ferroptotic FGF21 secretion
    Hironari Nishizawa, Mitsuyo Matsumoto, Mie Yamanaka, Riko Irikura, Kazuma Nakajima, Keisuke Tada, Yoshiaki Nakayama, Morichika Konishi, Nobuyuki Itoh, Ryo Funayama et al. · 2024 · Cell Reports
43. Astragaloside IV ameliorates cisplatin-induced liver injury by modulating ferroptosis-dependent pathways.
    Jianan Guo, Yi-Fei Le, Ai-Ni Yuan, Jing Liu, Hang Chen, Jian-Nan Qiu, Cui Wang, Xiaobing Dou, Xingyu Yuan, De-Zhao Lu · 2024 · Journal of Ethnopharmacology
44. Research Progress of Ferroptosis in Adiposity‐Based Chronic Disease (ABCD)
    Huijun Du, Xiaoying Ren, Juncai Bai, Wei Ping Yang, Yunan Gao, Shuang Yan · 2022 · Oxidative Medicine and Cellular Longevity
45. Neuroprotective Effects of Activin A against Cerebral Ischemia/Reperfusion Injury in Mice by Enhancing Nrf2 Expression to Attenuate Neuronal Ferroptosis
    Fengzhi Wang, Ming Ma, Jiahui Yang, Xiaohua Shi, Jiaoqi Wang, Zhongxin Xu · 2023 · ACS Chemical Neuroscience
46. The Cellular Stability Hypothesis: Evidence of Ferroptosis and Accelerated Aging-Associated Diseases as Newly Identified Nutritional Pentadecanoic Acid (C15:0) Deficiency Syndrome
    Stephanie K Venn-Watson · 2024 · Metabolites
47. Secondary Production of the Intertidal Macrofauna of Prainha Beach, Brazil
    Ricardo S. Cardoso, Valéria Gomes Veloso · 2003 · Dialnet (Universidad de la Rioja)
48. Metabolic dysfunction-associated steatotic liver disease: ferroptosis related mechanisms and potential drugs
    Baoqiang Zhu, Yuankui Wei, Mingming Zhang, Shiyu Yang, Rongsheng Tong, Wenyuan Li, Enwu Long · 2023 · Frontiers in Pharmacology
49. PPAR-α inhibits DHEA-induced ferroptosis in granulosa cells through upregulation of FADS2
    Ying Liu, Feng Ni, Jing Huang, Yuqin Hu, Jing Wang, Xuemei Wang, Xin Du, Hong Jiang · 2024 · Biochemical and Biophysical Research Communications
50. Ferroptosis: biology and role in liver disease
    Keisuke Hino, Sohji Nishina, Izumi Yanatori · 2025 · Journal of Gastroenterology
51. Contribution of classification based on ferroptosis-related genes to the heterogeneity of MAFLD
    Xin Dai, Rui Zhang, Bang-Mao Wang · 2022 · BMC Gastroenterology
52. Ferroptosis mediates decabromodiphenyl ether-induced liver damage and inflammation
    Yan Wang, Yue Zhang, Jinglong Xue, Leqiang Gao, Xiangyang Li, Moxuan Zhao, Dong Feng Zhao, Xianqing Zhou · 2023 · Ecotoxicology and Environmental Safety
53. Managing ferroptosis-related diseases with indirect dietary modulators of ferroptosis
    Lixing Cao, Shuang Zhao, Kai Han, Lihong Fan, Chong Zhao, Shutao Yin, Hongbo Hu · 2023 · The Journal of Nutritional Biochemistry
54. Study on the mechanism of puerarin against osteoarthritis from ferroptosis based on network pharmacology and bioinformatics
    Wenxiang Deng, Wenan Zhang, Qinghu He · 2023 · Naunyn-Schmiedeberg s Archives of Pharmacology
55. Machine learning identifies ferroptosis-related gene ANXA2 as potential diagnostic biomarkers for NAFLD
    Jingtong Qin, Peng Cao, Xuexuan Ding, Zeyao Zeng, Liyan Deng, Lianxiang Luo · 2023 · Frontiers in Endocrinology
56. Ferroptosis: a dual-edged sword in tumour growth
    Xiangye Zhao, Xiaoning Li, Yinghui Xu · 2024 · Frontiers in Pharmacology
57. Heme (dys)homeostasis and liver disease
    Tiago L. Duarte, Nicole Viveiros, Catarina Godinho, Delfim Duarte · 2024 · Frontiers in Physiology
58. Mitochondrial dysfunction in drug-induced hepatic steatosis: Recent findings and current concept
    Annie Borgne‐Sanchez, Bernard Fromenty · 2025 · Clinics and Research in Hepatology and Gastroenterology
59. Involvement of ferroptosis in metabolic dysfunction-associated steatohepatitis-related liver diseases
    Yiran Liu, Mingyu Zhang, Yujie Huang, Yu Zhang, Zhu Chen, Jia‐Lun Guan, Suhong Xia, Jiazhi Liao · 2025 · Journal of Molecular Medicine
60. Targeting ferroptosis as a therapeutic strategy for hepatotoxicity
    Negar Hemmati, Mahdieh Anoush, Bahman Abedi Kiasari, Alireza Torkamani · 2025 · Toxicology Reports
61. Lipid Peroxidation in Ferroptosis and Association with Nonalcoholic Fatty Liver Disease
    Shengnan Zhao, Guo Yan, Xunzhe Yin · 2023 · Frontiers in Bioscience-Landmark
62. Absence of gut microbiota alleviates iron overload-induced colitis by modulating ferroptosis in mice
    Ke Gu, Aimin Wu, Chen Liu, Bing Yu, Jun He, Xin Lai, Junzhou Chen, Yuheng Luo, Hui Yan, Ping Zheng et al. · 2024 · Journal of Advanced Research
63. Ferroptosis resistance cooperates with cellular senescence in the overt stage of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
    Antonella Vetuschi, Alfredo Cappariello, Paolo Onori, Eugenio Gaudio, Giovanni Latella, Simona Pompili, Roberta Sferra · 2022 · European Journal of Histochemistry
64. Ferroptosis and its emerging role in esophageal cancer
    Rezeye Maimaitizunong, Kai Wang, Hui Li · 2022 · Frontiers in Molecular Biosciences
65. Hepatic COX1 loss leads to impaired autophagic flux and exacerbates nonalcoholic steatohepatitis
    Qian Yu, Chang Li, Qinghui Niu, Jigang Wang, Zhaodi Che, Ke Lei, He Ren, Boyi Ma, Yixing Ren, Pingping Luo et al. · 2023 · Acta Pharmaceutica Sinica B
66. Dissecting the potential role of ferroptosis in liver diseases: an updated review
    Gaoyue Guo, Wanting Yang, Chao Sun, Xiaoyu Wang · 2023 · Free Radical Research
67. Sappanone A Alleviates the Severity of Carbon Tetrachloride-Induced Liver Fibrosis in Mice
    Qi, Jing, Li, Lanqian, Yan, Xueqing, Hua, Wenxi, Zhou, Zixiong · 2023 · Antioxidants
68. The role of TRIM family in metabolic associated fatty liver disease
    Jingyue Zhang, Ying‐Ming Zhang, Ze Ren, Dongmei Yan, Guiying Li · 2023 · Frontiers in Endocrinology
69. AK-1, a Sirt2 inhibitor, alleviates carbon tetrachloride-induced hepatotoxicity in vivo and in vitro
    Zixiong Zhou, Jing Qi, Jong-Won Kim, Myung‐Jo You, Chae Woong Lim, Bumseok Kim · 2020 · Toxicology Mechanisms and Methods
70. Ironing out MAFLD: Therapeutic targeting of liver ferroptosis
    Tuo Shao, Raymond T. Chung · 2024 · Cell Metabolism
71. Mechanisms of Neoantigen-Targeted Induction of Pyroptosis and Ferroptosis: From Basic Research to Clinical Applications
    Jie Yu, Qing Wang, Xiaoyun Zhang, Zhiliang Guo, Xiaodong Cui · 2021 · Frontiers in Oncology
72. Selenium Nanoparticles vs Selenite Fertilizers: Implications for Toxicological Profiles, Antioxidant Defense, and Ferroptosis Pathways
    Qi-Ting Fang, Zhonghua Liu, Kaixi Wang · 2025 · Journal of Agricultural and Food Chemistry
73. Genipin protects against acute liver injury by abrogating ferroptosis via modification of GPX4 and ALOX15-launched lipid peroxidation in mice
    Xiaofei Fan, Xiaoyu Wang, Yangyang Hui, Tianming Zhao, Lihong Mao, Binxin Cui, Weilong Zhong, Chao Sun · 2023 · APOPTOSIS
74. Si-Wu-Tang alleviates metabolic dysfunction-associated fatty liver disease by inhibiting ACSL4-mediated arachidonic acid metabolism and ferroptosis in MCD diet-fed mice
    Xiaoyong Xue, Le Wang, Ruiyu Wu, Yufei Li, Runping Liu, Zhi Ma, Kexin Jia, Yinhao Zhang, Xiaojiaoyang Li · 2024 · Chinese Medicine
75. Perfluorooctane sulfonate induces ferroptosis-dependent non-alcoholic steatohepatitis via autophagy-MCU-caused mitochondrial calcium overload and MCU-ACSL4 interaction
    Siyu Ren, Jianyu Wang, Zhanchen Dong, Jixun Li, Yu Ma, Ying C. Yang, Tian Gang Zhou, Tianming Qiu, Liping Jiang, Qiujuan Li et al. · 2024 · Ecotoxicology and Environmental Safety
76. Insights into the pathogenesis of gestational and hepatic diseases: the impact of ferroptosis
    Yilan You, Zhiwen Qian, Ying Jiang, Lingyan Chen, Danping Wu, Lu Liu, Feng Zhang, Xin Ning, Yan Zhang, Jianping Xiao · 2024 · Frontiers in Cell and Developmental Biology
77. A translational in vitro to in vivo study on chronic arsenic exposure induced pulmonary ferroptosis and multi-omics analysis of gut-lung axis correlation
    Sanaullah Sajid, Xu Chen, Yanqin Sun, Junjie Luo, Bin Zhang, Linkang Chen, Jieliang Huang, Chengze Lai, Yongchun Chen, Lianxian Guo · 2025 · Journal of Hazardous Materials
78. Transcriptomic analysis in zebrafish larvae identifies iron-dependent mitochondrial dysfunction as a possible key event of NAFLD progression induced by benzo[a]pyrene/ethanol co-exposure
    Muhammad Imran, Frédéric Chalmel, Odile Sergent, Bertrand Evrard, Hélène Le Mentec, Antoine Legrand, Aurélien Dupont, Maëlle Bescher, Simon Bucher, Bernard Fromenty et al. · 2022 · Cell Biology and Toxicology
79. Administration of Glutaredoxin-1 Attenuates Liver Fibrosis Caused by Aging and Non-Alcoholic Steatohepatitis
    Yuko Tsukahara, Beatriz Ferrán, Erika T. Minetti, Brian S. H. Chong, Adam C. Gower, Markus Michael Bachschmid, Reiko Matsui · 2022 · Antioxidants
80. Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC
    Xue Li, Shimin Chen, Yuanyuan Shi, Yuanjing Wang, X Wang, Qian Lin, Chao Wu, Wenshuo Fang, Peng Sun, Leina Ma · 2024 · Frontiers in Pharmacology
81. RNA-sequencing identifies novel transcriptomic signatures in intestinal failure-associated liver disease
    Lu Jiang, Nan Wang, Siyang Cheng, Yang Liu, Shanshan Chen, Ying Wang, Wei Cai · 2021 · Journal of Pediatric Surgery
82. Lipid metabolism: a molecular switch to control inflammation
    Shilei Cheng, Lanyun Xie, Jianbo Wu, Fan Yang · 2026 · International Immunopharmacology
83. Effect of P53 nuclear localization mediated by G3BP1 on ferroptosis in acute liver failure
    Wenyuan Li, Wei Li, Xun Li, Lu-Wen Wang, Yao Wang · 2023 · APOPTOSIS
84. Integration of transcriptomics and metabolomics analysis for unveiling the toxicological profile in the liver of mice exposed to uranium in drinking water
    Ruixia Wang, Yongjiu Chen, Jiahao Chen, Minghao Ma, Ming Xu, Sijin Liu · 2023 · Environmental Pollution
85. Bioinformatics analysis of ferroptosis-related genes and immune cell infiltration in non-alcoholic fatty liver disease
    Huan Zhang, Malina Axinbai, Yuqing Zhao, Jiaoyang Wei, Tongshuo Qu, Jingmin Kong, Yongqiang He, Liping Zhang · 2023 · European journal of medical research
86. Ferroptosis: An important mechanism of disease mediated by the gut-liver-brain axis
    Xin‐Xin Yu, Shihao Wang, Zhongjie Ji, Jiaqi Meng, Yunying Mou, Xinyi Wu, Xu Yang, Panyang Xiong, Mingxia Li, Yinghui Guo · 2024 · Life Sciences
87. Bergapten Ameliorates Renal Fibrosis by Inhibiting Ferroptosis
    Li Li, Wenqian Cai, Hao Zhang, Jiuren Tang, Yongjie Yang, Yang Huang, Qing Xi, Rongxin Zhang · 2025 · Phytotherapy Research
88. The Intestinal Thread of Fate: How the Microbiota Shapes the Story of Liver Disease
    Carlo Acierno, Riccardo Nevola, Luca Rinaldi, Ferdinando Carlo Sasso, Luigi Elio Adinolfi, Alfredo Caturano · 2025 · Livers
89. Obeticholic acid and ferrostatin-1 differentially ameliorate non-alcoholic steatohepatitis in AMLN diet-fed ob/ob mice
    Shengjie Li, Aoxiang Zhuge, Kaicen Wang, Jiafeng Xia, Qiangqiang Wang, Shengyi Han, Jian Shen, Lanjuan Li · 2022 · Frontiers in Pharmacology
90. Distinct Types of Cell Death and Implications in Liver Diseases: An Overview of Mechanisms and Application
    Yukun Wang, Chunxia Shi, Jin Guo, Yanqiong Zhang, Zuojiong Gong · 2023 · Journal of Clinical and Translational Hepatology
91. Importance of Autophagy in Mediating Cellular Responses to Iron Overload in Cardiomyocytes
    Eddie Tam, Chloe Reno, Khang Duy Nguyen, Sungji Cho, Gary Sweeney · 2022 · Reviews in Cardiovascular Medicine
92. The regulation and functions of ACSL3 and ACSL4 in the liver and hepatocellular carcinoma
    Jorlin Y. Liu, Mark G. Waugh · 2022 · Liver Cancer International
93. CDKN1A and EGR1 are key genes for endoplasmic reticulum stress-induced ferroptosis in MASH
    Qian Xu, Yanyu Chen, Huayu Zhang, Kun Zhou, Yuanqin Zhao, Wei Deng, Zhaoyue Wang, Liyuan Guo, Huiting Liu, Zhong Ren et al. · 2025 · Free Radical Biology and Medicine
94. Targeting ferroptosis in cardio‐metabolic‐diseases: Mechanisms and therapeutic prospects
    Jiabao Zhang, Jie Tong, Di‐Yang Sun, Jiang‐Tao Fu, Dongjie Li, Pei Wang · 2023 · Medicinal Research Reviews
95. Testosterone deficiency aggravates diet-induced non-alcoholic fatty liver disease by inducing hepatocyte ferroptosis via targeting BMAL1 in mice
    Yingying Fan, Yujie Ren, Liqun Deng, Dongying Lv, Jiayan Chen, Yun Ling, Jue Tu, Xiaoping Xu, Dejun Wang, Zhaowei Cai · 2024 · International Immunopharmacology
96. Life-threatening risk factors contribute to the development of diseases with the highest mortality through the induction of regulated necrotic cell death
    Muszka Zsuzsa, Viktória Jenei, Rebeka Mácsik, Evgeniya Mezhonova, Silina Diyab, Réka Csősz, Attila Bácsi, Anett Mázló, Gábor Koncz · 2025 · Cell Death and Disease
97. Killing hepatocellular carcinoma in the NAFLD/NASH stage: a comprehensive perspective on targeting regulated cell death
    Jianxin Xi, Shuang-Yin Lei, Jie Chen, Jiahui Liu, Chenhao Shan, Xun Sun, Qianqian Zheng, Xiaoju Shi · 2025 · Cell Death Discovery
98. Targeting AKT to treat liver disease: Opportunities and challenges
    Zeping Wang, Xinyue Dou, Qiyuan Shan, Yan Ning, Jiajun Wang, Tianyang Wang, Tianyang Cheng, Kao Shi, Sunan Li, Xin Han et al. · 2025 · Biochemical Pharmacology
99. Role of persistent necroinflammation in chronic tissue remodeling and organ fibrosis
    Sagar A. More, Aparajita Ghosh, Onkar P. Kulkarni, Shrikant R. Mulay · 2025 · American Journal of Physiology-Cell Physiology
100. Ferroptosis in cardiovascular diseases: molecular mechanisms and a novel therapeutic target
     Suli Yu, Zhen Pang, Hong Fang, Chi Liu · 2026 · Molecular Biomedicine